$5.94 Billion is the total value of SUVRETTA CAPITAL MANAGEMENT, LLC's 106 reported holdings in Q3 2021. The portfolio turnover from Q2 2021 to Q3 2021 was 68.4% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
UNH | Buy | UNITEDHEALTH GROUP INC | $279,423,000 | +0.9% | 715,113 | +3.4% | 4.71% | +13.6% |
MA | Buy | MASTERCARD INCORPORATEDcl a | $234,475,000 | +17.9% | 674,400 | +23.8% | 3.95% | +32.8% |
RH | Buy | RH | $223,382,000 | +8.2% | 334,951 | +10.1% | 3.76% | +21.9% |
OTIS | Buy | OTIS WORLDWIDE CORP | $222,118,000 | +3.5% | 2,699,539 | +2.8% | 3.74% | +16.5% |
TPR | Buy | TAPESTRY INC | $199,095,000 | -11.6% | 5,378,032 | +3.8% | 3.35% | -0.4% |
OPEN | Buy | OPENDOOR TECHNOLOGIES INC | $193,944,000 | +63.2% | 9,446,879 | +40.9% | 3.27% | +83.8% |
TMO | New | THERMO FISHER SCIENTIFIC INC | $186,145,000 | – | 325,810 | +100.0% | 3.14% | – |
IQV | Buy | IQVIA HLDGS INC | $168,441,000 | +16.9% | 703,187 | +18.2% | 2.84% | +31.6% |
TWLO | Buy | TWILIO INCcl a | $164,796,000 | +33.2% | 516,520 | +64.5% | 2.78% | +50.0% |
PWR | Buy | QUANTA SVCS INC | $158,077,000 | +37.2% | 1,388,834 | +9.2% | 2.66% | +54.6% |
ABC | Buy | AMERISOURCEBERGEN CORP | $147,502,000 | +9.7% | 1,234,845 | +5.1% | 2.48% | +23.6% |
PLAN | Buy | ANAPLAN INC | $131,841,000 | +23.3% | 2,165,238 | +8.0% | 2.22% | +38.9% |
CPRT | Buy | COPART INC | $121,070,000 | +10.9% | 872,764 | +5.4% | 2.04% | +24.9% |
CANO | Buy | CANO HEALTH INC | $106,753,000 | +23.2% | 8,419,011 | +17.6% | 1.80% | +38.8% |
PTON | Buy | PELOTON INTERACTIVE INC | $101,570,000 | +11.7% | 1,166,800 | +59.1% | 1.71% | +25.8% |
ALIT | New | ALIGHT INC | $95,858,000 | – | 8,350,000 | +100.0% | 1.62% | – |
NTRA | Buy | NATERA INC | $83,270,000 | +107.4% | 747,220 | +111.3% | 1.40% | +133.4% |
ADI | Buy | ANALOG DEVICES INC | $79,996,000 | +49.1% | 477,645 | +53.3% | 1.35% | +68.1% |
HWM | Buy | HOWMET AEROSPACE INC | $79,598,000 | +39.0% | 2,551,230 | +53.6% | 1.34% | +56.7% |
SQ | New | SQUARE INCcl a | $72,655,000 | – | 302,930 | +100.0% | 1.22% | – |
AGIO | Buy | AGIOS PHARMACEUTICALS INC | $60,537,000 | +11.2% | 1,311,748 | +32.8% | 1.02% | +25.3% |
MA | New | MASTERCARD INCORPORATEDcall | $60,010,000 | – | 172,600 | +100.0% | 1.01% | – |
RPRX | Buy | ROYALTY PHARMA PLC | $55,218,000 | +84.7% | 1,527,900 | +109.5% | 0.93% | +108.1% |
FULC | Buy | FULCRUM THERAPEUTICS INC | $54,783,000 | +221.2% | 1,941,969 | +19.3% | 0.92% | +262.0% |
New | WARBY PARKER INC | $53,050,000 | – | 1,000,000 | +100.0% | 0.89% | – | |
ITCI | Buy | INTRA-CELLULAR THERAPIES INC | $46,673,000 | +10.1% | 1,251,946 | +20.5% | 0.79% | +24.0% |
KURA | Buy | KURA ONCOLOGY INC | $46,080,000 | +33.2% | 2,460,202 | +48.3% | 0.78% | +50.1% |
STRO | Buy | SUTRO BIOPHARMA INC | $42,194,000 | +32.3% | 2,233,695 | +30.2% | 0.71% | +49.1% |
ESTC | New | ELASTIC N V | $40,376,000 | – | 271,000 | +100.0% | 0.68% | – |
MRTX | Buy | MIRATI THERAPEUTICS INC | $33,844,000 | +40.7% | 191,308 | +28.5% | 0.57% | +58.3% |
ARNA | New | ARENA PHARMACEUTICALS INC | $30,197,000 | – | 507,088 | +100.0% | 0.51% | – |
DCPH | Buy | DECIPHERA PHARMACEUTICALS IN | $29,295,000 | +22.6% | 862,126 | +32.1% | 0.49% | +38.4% |
INSM | Buy | INSMED INC | $27,505,000 | +119.1% | 998,732 | +126.4% | 0.46% | +146.3% |
KALV | Buy | KALVISTA PHARMACEUTICALS INC | $26,930,000 | -5.6% | 1,543,284 | +29.6% | 0.45% | +6.3% |
Buy | MARINUS PHARMACEUTICALS INC | $25,007,000 | -23.7% | 2,197,426 | +20.3% | 0.42% | -14.1% | |
MREO | Buy | MEREO BIOPHARMA GROUP PLCads | $22,124,000 | -19.3% | 9,142,067 | +5.7% | 0.37% | -9.0% |
FREY | New | FREYR BATTERY | $20,665,000 | – | 2,093,710 | +100.0% | 0.35% | – |
EYPT | Buy | EYEPOINT PHARMACEUTICALS INC | $17,762,000 | +43.3% | 1,704,589 | +23.7% | 0.30% | +61.6% |
XENE | Buy | XENON PHARMACEUTICALS INC | $17,709,000 | +60.1% | 1,158,961 | +95.1% | 0.30% | +80.6% |
AGLE | Buy | AEGLEA BIOTHERAPEUTICS INC | $17,154,000 | +17.7% | 2,157,727 | +3.0% | 0.29% | +32.6% |
PNT | New | POINT BIOPHARMA GLOBAL INC | $17,110,000 | – | 2,225,000 | +100.0% | 0.29% | – |
BOLT | Buy | BOLT BIOTHERAPEUTICS INC | $16,768,000 | +13.7% | 1,325,500 | +38.9% | 0.28% | +28.1% |
New | DICE THERAPEUTICS INC | $13,428,000 | – | 410,000 | +100.0% | 0.23% | – | |
KDNY | Buy | CHINOOK THERAPEUTICS INC | $13,366,000 | -2.2% | 1,047,468 | +8.2% | 0.22% | +10.3% |
New | ROCKET LAB USA INC | $12,098,000 | – | 750,000 | +100.0% | 0.20% | – | |
CMRX | Buy | CHIMERIX INC | $11,808,000 | +78.9% | 1,907,620 | +131.2% | 0.20% | +101.0% |
New | CAZOO GROUP LTD | $11,730,000 | – | 1,509,700 | +100.0% | 0.20% | – | |
TERN | Buy | TERNS PHARMACEUTICALS INC | $11,730,000 | -15.0% | 1,125,736 | +0.1% | 0.20% | -3.9% |
INZY | Buy | INOZYME PHARMA INC | $11,432,000 | +83.7% | 986,400 | +170.1% | 0.19% | +107.5% |
BCAB | New | BIOATLA INC | $10,427,000 | – | 354,190 | +100.0% | 0.18% | – |
GMTX | Buy | GEMINI THERAPEUTICS INC | $8,637,000 | -37.5% | 2,137,823 | +0.1% | 0.15% | -29.5% |
New | EVOLV TECHNOLOGIES HLDNGS IN | $8,207,000 | – | 1,367,870 | +100.0% | 0.14% | – | |
CHRS | New | COHERUS BIOSCIENCES INC | $7,864,000 | – | 489,333 | +100.0% | 0.13% | – |
New | NERDY INC | $6,993,000 | – | 700,000 | +100.0% | 0.12% | – | |
New | ARCHER AVIATION INC | $6,660,000 | – | 750,000 | +100.0% | 0.11% | – | |
ACIU | New | AC IMMUNE SA | $6,465,000 | – | 963,500 | +100.0% | 0.11% | – |
New | FRESHWORKS INC | $6,404,000 | – | 150,000 | +100.0% | 0.11% | – | |
New | IMMUNEERING CORP | $5,310,000 | – | 200,000 | +100.0% | 0.09% | – | |
MAAC | New | MONTES ARCHIMEDES ACQUISITIO | $4,675,000 | – | 500,000 | +100.0% | 0.08% | – |
New | NUVALENT INC | $4,510,000 | – | 200,000 | +100.0% | 0.08% | – | |
ORIC | New | ORIC PHARMACEUTICALS INC | $3,118,000 | – | 149,100 | +100.0% | 0.05% | – |
New | VOLTA INC | $2,595,000 | – | 300,000 | +100.0% | 0.04% | – | |
ALITWS | New | ALIGHT INC*w exp 05/26/202 | $2,362,000 | – | 774,375 | +100.0% | 0.04% | – |
SYBX | New | SYNLOGIC INC | $183,000 | – | 60,000 | +100.0% | 0.00% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR/A filed 2021-11-16
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
ADOBE SYSTEMS INCORPORATED | 33 | Q4 2021 | 13.2% |
CONSTELLATION BRANDS INC | 20 | Q4 2018 | 10.9% |
AMAZON COM INC | 20 | Q3 2023 | 8.0% |
UNITEDHEALTH GROUP INC | 20 | Q3 2023 | 5.7% |
IQVIA HLDGS INC | 19 | Q3 2023 | 7.3% |
RESTAURANT BRANDS INTL INC | 18 | Q3 2019 | 8.9% |
UNION PAC CORP | 17 | Q2 2023 | 5.1% |
META PLATFORMS INC | 16 | Q3 2023 | 10.9% |
COPART INC | 15 | Q4 2021 | 2.3% |
SUTRO BIOPHARMA INC | 15 | Q3 2023 | 1.9% |
View SUVRETTA CAPITAL MANAGEMENT, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
Zura Bio Ltd | June 15, 2023 | 2,850,000 | 6.6% |
InflaRx N.V. | April 24, 2023 | 5,733,910 | 10.3% |
Benitec Biopharma Inc. | April 18, 2023 | 3,020,214 | 10.0% |
Aeglea BioTherapeutics, Inc. | February 13, 2023 | 6,376,373 | 10.0% |
Bolt Biotherapeutics, Inc.Sold out | February 13, 2023 | 0 | 0.0% |
Cano Health, Inc.Sold out | February 13, 2023 | 0 | 0.0% |
CHIMERIX INCSold out | February 13, 2023 | 0 | 0.0% |
Disc Medicine, Inc.Sold out | February 13, 2023 | 0 | 0.0% |
OTONOMY, INC.Sold out | February 13, 2023 | 0 | 0.0% |
Sio Gene Therapies Inc.Sold out | February 13, 2023 | 0 | 0.0% |
View SUVRETTA CAPITAL MANAGEMENT, LLC's complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
3 | 2024-05-02 |
SC 13D | 2024-04-29 |
SC 13G | 2024-04-15 |
13F-HR | 2024-02-14 |
SC 13G/A | 2024-02-13 |
SC 13G/A | 2024-02-13 |
SC 13G/A | 2024-02-13 |
SC 13G/A | 2024-02-13 |
SC 13G/A | 2024-02-13 |
SC 13G/A | 2024-02-13 |
View SUVRETTA CAPITAL MANAGEMENT, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.